Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.07% |
| 2 | Technology | 14.35% |
| 3 | Financials | 11.23% |
| 4 | Consumer Discretionary | 9.93% |
| 5 | Real Estate | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Omega Flex
OFLX
$290M
| $1.82M | ﹤0.01% |
23,700
-1,000
| -4% | -$84K |
|
|
PEGI
2377
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $1.82M | ﹤0.01% |
+78,700
| New | +$1.76M |
|
|
DZSI
2378
DELISTED
DZS Inc. Common Stock
DZSI
| $1.81M | ﹤0.01% |
139,697
+14,200
| +11% | +$169K |
|
|
VRTV
2379
DELISTED
VERITIV CORPORATION
VRTV
| $1.81M | ﹤0.01% |
93,400
+18,900
| +25% | +$436K |
|
2380
Heron Therapeutics
HRTX
$62.8M
| $1.81M | ﹤0.01% |
+97,400
| New | +$1.95M |
|
2381
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.11B
| $1.81M | ﹤0.01% |
61,700
+25,900
| +72% | +$748K |
|
|
INFI
2382
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.8M | ﹤0.01% |
1,002,006
+110,806
| +12% | +$178K |
|
2383
Harvard Bioscience
HBIO
$30.1M
| $1.8M | ﹤0.01% |
90,100
+27,950
| +45% | +$819K |
|
2384
Axcelis
ACLS
$4.26B
| $1.8M | ﹤0.01% |
119,599
-64,900
| -35% | -$1.16M |
|
|
DO
2385
DELISTED
Diamond Offshore Drilling
DO
| $1.8M | ﹤0.01% |
202,900
-649,600
| -76% | -$6.23M |
|
2386
Alamo Group
ALG
$2.03B
| $1.8M | ﹤0.01% |
18,000
-900
| -5% | -$89.8K |
|
2387
Assembly Biosciences
ASMB
$625M
| $1.8M | ﹤0.01% |
11,108
+8,575
| +339% | +$1.63M |
|
|
GURE
2388
Gulf Resources
GURE
$4.86M
| $1.79M | ﹤0.01% |
35,729
+510
| +1% | +$29.7K |
|
2389
StoneX
SNEX
$7.95B
| $1.79M | ﹤0.01% |
228,440
-40,009
| -15% | -$299K |
|
2390
Colony Bankcorp
CBAN
$472M
| $1.78M | ﹤0.01% |
105,300
+26,600
| +34% | +$454K |
|
2391
LeMaitre Vascular
LMAT
$1.87B
| $1.78M | ﹤0.01% |
+63,600
| New | +$1.77M |
|
2392
LGL Group
LGL
$93.3M
| $1.77M | ﹤0.01% |
577,614
+46,249
| +9% | +$137K |
|
|
RIBT
2393
DELISTED
RiceBran Technologies
RIBT
| $1.77M | ﹤0.01% |
61,008
-3,680
| -6% | -$110K |
|
2394
Kewaunee Scientific
KEQU
$105M
| $1.77M | ﹤0.01% |
92,627
+727
| +0.8% | +$15.6K |
|
2395
Ark Restaurants
ARKR
$20.2M
| $1.76M | ﹤0.01% |
85,900
+2,880
| +3% | +$57.9K |
|
2396
IRIDEX
IRIX
$14.6M
| $1.76M | ﹤0.01% |
385,862
+10,808
| +3% | +$52.7K |
|
|
WSTL
2397
DELISTED
Westell Technologies Inc
WSTL
| $1.75M | ﹤0.01% |
932,360
-809
| -0.1% | -$1.61K |
|
2398
i3 Verticals
IIIV
$323M
| $1.74M | ﹤0.01% |
+59,200
| New | +$1.46M |
|
2399
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.24B
| $1.74M | ﹤0.01% |
21,647
+6,300
| +41% | +$493K |
|
|
TBHC
2400
DELISTED
The Brand House Collective
TBHC
| $1.74M | ﹤0.01% |
768,100
+291,100
| +61% | +$1.37M |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.